Autologous haematopoietic stem cell transplantation for secondary progressive multiple sclerosis: an exploratory cost-effectiveness analysis.
about
Hematopoietic stem cell therapy for multiple sclerosis: top 10 lessons learned.The role of autologous haemopoietic stem cell transplantation in the treatment of autoimmune disorders.Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow TransplantationCost-effectiveness of multiple sclerosis disease-modifying therapies: a systematic review of the literature.Transplantation for autoimmune diseases in north and South America: a report of the Center for International Blood and Marrow Transplant Research.Hematopoietic SCT for the treatment of multiple sclerosis.Squinting through layers of fog: assessing the cost effectiveness of treatments for multiple sclerosis.Feasibility of cell therapy in multiple sclerosis: a systematic review of 83 studies.Cost-effectiveness analyses in multiple sclerosis: a review of modelling approaches.Autologous hematopoietic cell transplantation in multiple sclerosis.Cell Therapy for Multiple Sclerosis.Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis.Updated views on autologous hematopoietic stem cell transplantation for treatment of multiple sclerosis.A review on stem cell therapy for multiple sclerosis: special focus on human embryonic stem cells.An economic analysis of autologous hematopoietic stem cell transplantation (AHSCT) in the treatment of new onset type 1 diabetes.
P2860
Q34314312-CF0836F9-4D10-4030-AFBC-78E76E55389EQ34500124-2A2F31D1-7F59-4594-8EC0-6D0467401F0AQ36020897-87716FB0-9772-4087-9DDA-E369378ECBE6Q36469022-A1F0E801-4FBB-4763-AB7D-A3591630A6CFQ37632215-FDD97A04-EAB5-4BE4-A09F-61CC996C8CBDQ37778984-C032AE11-4ED4-4D13-B94B-99E010DA2000Q38103515-F1733485-8F8E-4B38-824D-718AF5C9274DQ38186029-696B95B9-2DC5-4270-A023-32670A068D96Q38197076-A55BB00E-C577-4156-893D-68D35978C1AEQ38818703-8986689C-0C88-4BED-8C9C-6FF82D74BF32Q39233323-23333B4E-5A9E-4E6A-AFA5-FD43BE4AE519Q39378263-98FC7799-3F7E-46CE-9156-1AC0CEB5AE42Q48881267-FBEA29B7-DB60-4887-985B-9A5976C6597EQ52372446-6B5EA5A3-005B-4825-9597-2956D379C994Q53587963-41A1F69E-B3AB-47BF-A11A-EFE686BA4D64
P2860
Autologous haematopoietic stem cell transplantation for secondary progressive multiple sclerosis: an exploratory cost-effectiveness analysis.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Autologous haematopoietic stem ...... y cost-effectiveness analysis.
@en
Autologous haematopoietic stem ...... y cost-effectiveness analysis.
@nl
type
label
Autologous haematopoietic stem ...... y cost-effectiveness analysis.
@en
Autologous haematopoietic stem ...... y cost-effectiveness analysis.
@nl
prefLabel
Autologous haematopoietic stem ...... y cost-effectiveness analysis.
@en
Autologous haematopoietic stem ...... y cost-effectiveness analysis.
@nl
P2093
P2860
P50
P356
P1476
Autologous haematopoietic stem ...... y cost-effectiveness analysis.
@en
P2093
B Sharrack
C Confavreux
D Farge-Bancel
P Tappenden
R Akehurst
R Saccardi
P2860
P2888
P304
P356
10.1038/BMT.2009.305
P407
P577
2009-10-26T00:00:00Z
P5875
P6179
1003898004